Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment

ClinicalTrials.gov ID: NCT06400511

Public ClinicalTrials.gov record NCT06400511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis

Study identification

NCT ID
NCT06400511
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Famy Life Sciences, a Viatris Company
Industry
Enrollment
477 participants

Conditions and interventions

Conditions

Interventions

  • Pimecrolimus 0.3% Ophthalmic Ointment Drug
  • Placebo Ophthalmic Ointment Drug

Drug

Eligibility (public fields only)

Age range
2 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 21, 2024
Primary completion
Sep 8, 2025
Completion
Oct 14, 2025
Last update posted
Jan 6, 2026

2024 – 2025

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Clinical Investigative Site Pheonix Arizona 85032
Clinical Investigator Site Garden Grove California 92843
Clinical Investigator Site Glendale California 91204
Clinical Investigator Site Inglewood California 90301
Clinical Investigator Site Newport Beach California 92663
Clinical Investigator Site Petaluma California 94954
Clinical Investigator Site Rancho Cordova California 95670
Clinical Investigator Site Aurora Colorado 80045
Clinical Investigator Site Crystal River Florida 34429
Clinical Investigator Site Largo Florida 33773
Clinical Investigator Site Tampa Florida 33603
Clinical Investigator Site Atlanta Georgia 30339
Clinical Investigator Site Morrow Georgia 30260
Clinical Investigator Site Pittsburg Kansas 66762
Clinical Investigator Site Louisville Kentucky 40206
Clinical Investigator Site Havre de Grace Maryland 21078
Clinical Investigator Site Medina Minnesota 55340
Clinical Investigator Site Kansas City Missouri 64154
Investigative Site St Louis Missouri 63131
Clinical Investigator Site Washington Missouri 63090
Clinical Investigator Site Garner North Carolina 27529
Clinical Investigator Site Cincinnati Ohio 45242
Clinical Investigator Site Cranberry Township Pennsylvania 16066
Clinical Investigator Site Smyrna Tennessee 37167
Clinical Investigator Site Austin Texas 78731
Clinical Investigator Site Lakeway Texas 78738
Clinical Investigator Site San Antonio Texas 78229
Clinical Investigator Site Clinton Utah 84015
Clinical Investigator Site Lynchburg Virginia 24502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06400511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 6, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06400511 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →